Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00514371
Status:
COMPLETED
Last Update Posted:
2015-12-07
First Post:
2007-08-08
Brief Title:
A Study of Tanespimycin KOS-953 in Patients With Relapsed-refractory Multiple Myeloma
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2009-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-08
First Submit QC Date:
August 8 2007
Study First Post Date:
2007-08-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-09-10
Disp First Submit QC Date:
September 10 2010
Disp First Post Date:
2010-09-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-11-06
Last Update Post Date:
2015-12-07
Last Update Post Date Type:
ESTIMATED